F

Researcher Profile

Fred Lublin

🏛 Icahn School of Medicine at Mount Sinai, New York, New York

5

Publications

2,294

Citations

10

Co-Authors

4

Active Years

Publications

Journal Article The Lancet Neurology Oct 01, 2025

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

Xavier Montalban · Christine Lebrun-Frénay · Jiwon Oh · Georgina Arrambide +52 more

10.1016/s1474-4422(25)00270-4 184 citations

Journal Article The Lancet Neurology Jul 01, 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John F Foley · Gilles Defer · Lana Zhovtis Ryerson · Jeffrey A Cohen +96 more

10.1016/s1474-4422(22)00143-0 100 citations

Journal Article JAMA Neurology May 01, 2021

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

Ludwig Kappos · Robert J. Fox · Michel Burcklen · Mark S. Freedman +13 more

10.1001/jamaneurol.2021.0405 200 citations

Journal Article Brain Dec 11, 2021

Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma

Achilles Ntranos · Hye-Jin Park · Maureen Wentling · Vladimir Tolstikov +9 more

10.1093/brain/awab320 77 citations

Journal Article New England Journal of Medicine Jan 19, 2017

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser · Amit Bar-Or · Giancarlo Comi · Gavin Giovannoni +17 more

10.1056/nejmoa1601277 1,733 citations

Publication Timeline

2025

1

2022

1

2021

2

2017

1

Frequent Co-Authors

Xavier Montalban

Jeffrey A Cohen

Joep Killestein

Helmut Butzkueven

Hans-Peter Hartung

Anneke Van der Walt

Gavin Giovannoni